SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 59 filers reported holding SAVARA INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,685,000 | +26.7% | 1,220,905 | +56.0% | 0.01% | +22.2% |
Q2 2021 | $1,330,000 | -18.8% | 782,582 | -0.6% | 0.01% | -30.8% |
Q1 2021 | $1,638,000 | +2825.0% | 787,650 | +1519.4% | 0.01% | – |
Q4 2020 | $56,000 | -75.9% | 48,639 | -77.2% | 0.00% | -100.0% |
Q3 2020 | $232,000 | -73.4% | 213,025 | -39.1% | 0.00% | -77.8% |
Q2 2020 | $872,000 | +159.5% | 350,021 | +121.0% | 0.01% | +125.0% |
Q1 2020 | $336,000 | -77.6% | 158,369 | -52.7% | 0.00% | -73.3% |
Q4 2019 | $1,499,000 | +1010.4% | 334,687 | +554.7% | 0.02% | +650.0% |
Q3 2019 | $135,000 | – | 51,118 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |